Featured Editorial

  1. FDA Modernizes Container Closure Guidance: What Is Changing And Why It Matters 10/1/2026

    The proposed revision reflects changes in packaging technology, drug delivery systems, quality risk management, and more that have occurred since 1999's guidance.

  2. Engineering Better ADCs, Part 2: Characterization, CMC, And More 10/1/2026

    Let's take a closer look at antigen selection and tumor biology, PK and PD, analytical characterization, CMC, toxicity, and more.

  3. What Patients Actually Want From Connected Drug Delivery 9/29/2026

    A recent survey conducted with BioPhorum members revealed that the most critical aspect of digital healthcare for drug delivery devices. Let's take a closer look.

  4. Beyond Connectivity: Where Digital Technologies Create Real Value In Drug Delivery 9/29/2026

    Where can digital technologies can solve real problems for patients, healthcare providers, and industry, while avoiding unnecessary complexity? Here's where the strongest value propositions currently sit.

  5. Engineering Better ADCs, Part 1: MoA, Conjugation Chemistry, And More 9/24/2026

    The field has evolved considerably in antibody–drug conjugate (ADC) science. In this first article of a two-part series, let's discuss how to engineer better ADCs, covering MoA, conjugation chemistry, and more.

  6. From Albumin To Oncology: Can Chemical Engineering Unlock Solid Tumor Delivery? 9/23/2026

    We discuss how selective albumin binding improved tumor delivery in preclinical studies and what these findings could mean for the future of siRNA-based cancer therapies.

  7. A Practical Framework For Selecting Long-Acting Injectable Platforms Across Therapeutic, Product, And Delivery Constraints 9/22/2026

    Platform selection for long-acting injectables is increasingly complex because therapeutic modalities, delivery systems, and target product expectations have all diversified. Can your selected platform meet the needs of your product?

  8. Using Low-Intensity Focused Ultrasound To Open The Blood–Brain Barrier 9/11/2026

    We caught up with Davinder Ramsingh, MD, to talk about the potential of using low-intensity focused ultrasound (LIFU) to open the blood–brain barrier.

  9. Engineering Medical Devices To Improve Oral Delivery Of Biopharmaceuticals 9/10/2026

    Two approved GLP-1 pills validated the demand — and exposed the ceiling that only delivery devices can break.

  10. Oral Combination Therapies: Navigating Development Complexities 9/10/2026

    We discuss how delivery strategy influences development decisions, learnings from advancing IHL-42X, and Latham's perspective on the future of patient-centric drug delivery.